Growth I. Gp Llc M33 serves as Executive at Oncology Institute, Inc., where they oversee executive responsibilities. Since joining the company, Growth I. Gp Llc M33 has executed 2 insider transactions totaling $20.7M, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 4, 2025 involved selling 6,018,168 shares valued at $18.6M.
Growth I. Gp Llc M33 currently holds 7,932,389 shares of Oncology Institute, Inc. (TOI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Growth I. Gp Llc M33 has been a net seller of TOI stock. They have purchased $0 and sold $20.7M worth of shares.
Growth I. Gp Llc M33's most recent insider trade was on Sep 4, 2025, when they sold 6,018,168 shares at $3.09 per share.
Get notified when new Form 4 filings are submitted
| $3.09 |
| Discretionary |